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ABSTRACT 
Thyroid disease is quite common. The cardiovascular clinical manifestations of hyperthyroidism 
are palpitation, systolic hypertension, fatigue, or with the basis of existing heart disease, angina 
or heart failure. In men, the disease is more frequently to develop into congestive heart failure 
than in women, thus more exploration is needed. This case report discussed a 42-year-old male 
patient who was admitted to the emergency department due to palpitations, shortness of breath 
aggravated with activity and lie down position, and alleviated with resting, cough with white 
sputum, epigastric pain, and constipation since the past 3 days. He was diagnosed with a history 
of hyperthyroidism and congestive heart disease 1 year ago and routinely consumed 
propylthiouracil (PTU). He had a history of herniotomy 10 days before admission. The patient 
did not have a history of hypertension, diabetes mellitus, or hypercholesterolemia. The patient 
has a smoking habit of up to 3 packs daily since a teenager. The patient was diagnosed with 
hyperthyroid heart disease (congestive heart failure, atrial fibrillation, and coronary heart 
disease) with comorbid of electrolyte imbalance, hypoalbuminemia, and thrombocytopenia. The 
patient was treated in the Intensive Care Unit (ICU) and was given oxygen therapy, crystalloid 
infusion, anti-thyroid drug, beta-blocker, diuretics, digitalis, anti-angina, anti-thrombotic, and 
adjunct therapy. The patient was treated for 8 days in ICU, followed by 2 days in the ward with 
a good outcome. Early detection and intervention followed by close monitoring is key 
management for the patient with hyperthyroid heart disease, especially in a male patient, to 
achieve a better outcome. 
Keywords: Atrial fibrillation; congestive heart failure; coronary heart disease; hyperthyroidism; 
hypoalbuminemia 
 
Introduction 
Thyroid disease is quite common. Current data estimate 9% to 15% of the adult 
female population and smaller presentation in the adult male population with this 
disease. Prevalence occurs because of the autoimmune effects that underlie the onset of 
this disease, such as Grave's disease and Hashimoto's disease. Nonetheless, as this 
disease is a gender-specific, but with increasing age, the prevalence between male and 
female sex are equal.1 
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The cardiovascular clinical manifestations of hyperthyroidism are palpitation, 
systolic hypertension, fatigue, or with the existing heart disease, angina or heart failure. 
Sinus tachycardia is found in 40% of patients and 15% with atrial fibrillation in 
hyperthyroid patients.2 
In elderly patients with hyperthyroidism, called apatetic hyperthyroidism, 
thyrotoxicosis can only be seen in cardiovascular manifestations, including atrial 
fibrillation, and may be resistant to therapy until the condition of hyperthyroidism is 
controlled. Angina pectoris and congestive heart failure are rare unless they are related 
to the existing heart disease and many cases of symptoms diminish after the 
hyperthyroidism is resolved.2 We present a case of hyperthyroid heart disease 
(congestive heart failure, atrial fibrillation, and coronary heart disease) with comorbid 
of electrolyte imbalance, hypoalbuminemia, and thrombocytopenia. This case 
underlines the importance of early detection and intervention followed by close 
monitoring in patient with hyperthyroid heart disease. 
Case  
 A 42-years-old male, was admitted to hospital upon complaining of palpitations 
for the last 2 days. He had shortness of breath aggravated with activity and lie down 
position, and alleviated with resting since 2 days ago. He also reported stomachache, 
distended abdomen, and bloating for the last 3 days. The complaint was accompanied 
by constipation and unable to pass gas for the past 2 days. Pain in the pit of his stomach 
was also reported for the past 3 days. The patient also complained of coughing, 
occasionally accompanied by white sputum.  
The patient had a history of similar complaint 1 year ago and been diagnosed 
with hyperthyroidism. Since then, he routinely consumed PTU medication every day. 
When diagnosed as having hyperthyroid 1 year previously, he was found to already 
have a swollen heart. Patient had a hernia that he have been felt since December 2015 
and undergone surgery in Aloei Saboe Hospital 10 days previously. The patient did not 
have a history of hypertension, diabetes mellitus or hypercholesterolemia. Likewise, 
there was no hypertension, diabetes mellitus, hypercholesterolemia, goiter, or heart 
disease in the patient’s family. The patient had a marital problem, and was in divorce 
process since 1 year previously. Patient also have a smoking habit up to 3 packs/day 
since teenager. 
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In the emergency department, the blood pressure was 130/80 mmHg, the pulse 
rate was 80 times per minute irregular, breathing was 24 times per minute, body 
temperature was 35.50C and oxygen saturation was 98%. The patient appears to be 
moderately ill but was still conscious. There was no cyanosis, anemia, or jaundice on 
physical examination. Exophthalmus in both eyes were found and there was an increase 
of jugular venous pressure. No enlargement of the thyroid gland was found. On 
examination, the lungs were found within normal limits, while there was irregular heart 
I/II sounds accompanied by gallop S3. On examination, the abdomen appeared 
distended, there was a scar of surgical incision on the lower right abdomen, increased 
bowel sounds, epigastric tenderness, and unpalpable of the liver and spleen. In the 
extremities, pitting edema was found but the acral was still warm. 
On routine blood tests obtained in the emergency department, Hb 13.4 g% 
(reference value 11.0 - 16.5 gr%), Leukocytes 4,600/mcl (reference value 3,500-
10,000/mcl), Platelet 91,000/mcl (reference value 150,000-390,000/mcl), and 
Hematocrit 30.4% (reference value 35-50%). On kidney function, liver function, lipid 
profile, and electrolyte serum tests obtained on emergency department, Ureum 14 mg/dl 
(reference value 10-50 mg/dl), Creatinine 0.71 mg / dl (reference value 0.7 - 1.5 mg/dl), 
SGOT 37 U/L (reference value 11-41 U/L) and SGPT 31 U/L (reference value 10-41 
U/L), Total Cholesterol 106 mg/dl (reference value 140-199 mg/dl), LDL Cholesterol 
76 mg/dl (reference value <130 mg/dl), and HDL Cholesterol 25 mg/dl (reference value 
L:35-65 mg/dl P:35-80 mg/dl), Sodium 131.2 mmol/L (reference value 135-145 
mmol/L), Potassium 4.26 mmol/L (reference value 3.5 - 5.0 mmol/L), and Chloride 
106,9 mmol/L (reference value 98-106 mmol/L). On initial ECG in the emergency 
department, we found Atrial Fibrillation Normo Ventricular Response HR 80x/minutes, 
Left Ventricular Hypertrophy, and Normoaxis. The patient was diagnosed in the 
emergency department with Hyperthyroid Heart Disease (Atrial Fibrillation Normo 
Ventricular Response HR 80x/minutes and Congestive Heart Failure), Hyperthyroid on 
treatment (PTU), Imbalance Electrolyte, and Thrombocytopenia. Patient was decided to 
get closely monitoring in Intensive Care Unit (ICU). 
During treatment in the ICU, the patient had clinically improved condition 
where on day 5, symptoms significantly decrease.  Based on several hematology test 
(day 2 and day 3), thrombocytopenia still persist with value 113,000 and 91,000, 
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respectively but without signs of bleeding. The electrolyte level on day 3 is still 
abnormal, with mild hyponatremia (Na 131,2 mmol/L) but was corrected into the 
normal limit on day 6 (Na 142 mmol/L) without any specific treatment. For sharpen the 
diagnosis, we performed protein and albumin level tests (on 4th-day care), and urinalysis 
(on 5th-day care). On examination of protein level tests, it revealed total protein 4.9 g/dl 
(reference value 6.2 -8.4 g/dl) and Albumin 2.4 g/dl (reference value 3.5-5.5 g/dl). From 
urinalysis, protinuria was not found. Examination of thyroid hormone function cannot 
be conducted due to lack of resources. 
During treatment in the ICU, serial electrocardiography (ECG) monitoring was 
performed and various abnormalities were found (Table 1).  Moreover, we performed  
imaging examination on day 5 to help establish the diagnosis (Figure 1). Chest X-ray 
examination in postero-anterior position found cardiomegaly with cardiogenic acute 
lung oedem (ALO) signs, accompanied by bilateral pleural effusion. Whereas the 
abdomen ultrasonography (USG) examination was found hepatomegaly with signs of 
liver congestion. No free fluid was found in the peritoneal cavity. Finally, the patient 
was diagnosed with hyperthyroid heart disease (congestive heart failure, atrial 
fibrillation, and coronary heart disease) with comorbid of electrolyte imbalance, 
hypoalbuminemia, and thrombocytopenia. 
The patient was treated in ICU for 8 days, followed by 2 days in ward with good 
outcome. The given treatment were oxygen therapy, crystalloid infusion, anti-thyroid 
drug, beta-blockers, diuretics, digitalis, anti-angina, anti-thrombotic and adjunctive 
agent. Summary of daily follow up and detailed treatment given is shown in Table 2. 
Discussion 
 Patient was a 42 years old male. Based on the literature, the prevalence of 
hyperthyroidism is more common in middle age while women are more frequent than 
men with a ratio of 1: 5.1 This is a rare case, but in men is more frequent to develop into 
congestive heart failure than in women, so we must give more attention in this 
situation.2 
Patient present with a major complaint of chest palpitations since the last 2 days 
accompanied by shortness of breath. Patients had a history of being diagnosed with 
hyperthyroidism 1 year ago and routinely consumed PTU drugs. This is a typical 
complaint in hyperthyroidism disorders and often makes patients come to see a doctor.3 
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The patient also complained that his stomach feels bloated in the past 3 days and 
felt enlarged, which has made the patient felt uncomfortable. The patient also couldn’t 
defecate and passing gas in 2 days. Patient also complained of heartburn in the past 3 
days. These were non-specific complaints in patient who initially present with 
hyperthyroidism. 
Patient also complained of coughing, occasionally, accompanied by white 
sputum in the past 3 days. This is not a typical complaint in hyperthyroidism, but can be 
a sign of heart failure.4 
On the psychosocial aspect, the patient was currently having a marriage problem 
and undergoing divorce process in court since 1 year previously. Patient also have 
smoking habits up to 3 packs/day since he was a teenanger. It is suspected that this habit 
aggravate the patient's hyperthyroidism condition, especially complications of  heart 
failure abnormalities.5 
From initial vital signs in emergency department, there were two data that 
support the diagnosis of hyperthyroidism, the first data was irregular heart beat and the 
second data was rapid breathing, up to 24 x/minutes. From head to toe physical 
examination found a positive exophthalmus (+/+), increased JVP, normal lung 
examination, irregular heart rhythm accompanied by gallop sound S3, pitting edema in 
all the extremities showed a typical hyperthyroidism with complications of hyperthyroid 
heart disease (atrial fibrillation and congestive heart failure).4,6 
From the abdominal examination it was shown that the abdomen appeared 
distended, there was a scar of surgical incision on the lower right abdomen (from hernia 
surgery 10 days previously at other regional hospital), increased bowel sound, epigastric 
tenderness, and unpalpable of the liver and spleen.These were not specific finding of 
hyperthyroidism condition, but rather leads to the diagnosis of ileus and dyspepsia 
syndrome. After several days of follow-up, it was thought that the cause of abdominal 
abnormalities was ascites, on the basis of positive shifting dullness on physical 
examination, accompanied by laboratory results of hypoalbuminemia and 
hypoproteinemia. Although abdominal ultrasound examination was found no free fluid 
in the pertitoneal cavity, buttherewashepatomegalywithhepaticcongestivesigns, and 
bilateral pleuraleffusion. Related to the main disease of the patient, hyperthyroidism, 
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these were in accordance with complicationsofcongestiveheartfailure,experiencedbythe 
patient.4 
Routine blood tests showed thrombocytopenia that still persist until on the 3rd-
day care. This was probably due to the side effect of long term use of PTU, as has been 
reported in a study and a case report.7 However, the patient's condition was different 
from that reported in the study because there were no signs of bleeding in this patient. 
Examination of kidney function (urea, creatinine) and liver function (SGOT, 
SGPT) was within normal limits. This was in accordance with the condition of 
hyperthyroidism, and eliminates other possible diagnoses such as hepatic cirrhosis and 
chronic kidney failure which can also provide complaints and similar physical 
examinations findings. Examination of lipid profiles was found a decrease HDL, which 
supports hyperthyroidism in the patient.8  
Examinations of albumin and serum proteinwere found hypoalbuminemia and 
hypoproteinemia. The result of urine examination wasfound no proteinuria. This is in 
accordance with the condition of hyperthyroidism and eliminates other possible 
diagnoses such as liver cirrhosis and chronic kidney failure which can also provide a 
similar picture of laboratory results. Serum electrolyte examination showed a sign of 
electrolyte imbalance in the form of hyponatremia and hyperchloremia, which is not 
typical in patients with hyperthyroidism. The patient was not tested for thyroid 
hormones, neither TSH, free T4, nor T3, due to cost constraints and the hospital 
availability of such examination. Based on recent guideline, it is very recommended to 
perform thyroid testing for management of thyroid dysfunction coexistent with 
cardiovascular disease, especially for patient that have atrial fibrillation and heart failure 
as like as our patient condition.9  
Serial ECG examinations showed  various abnormalities, including atrial 
fibrillation, PVC/VES, T wave inversion, and signs of LVH. Atrial fibrillation is 
disorder that is commonly found in hyperthyroid heart disease patients.4 PVC/VES is a 
disorder that is rarely found in cases of hyperthyroidism, except if the patient already 
has an underlying heart abnormality. There is a possibility of underlying Coronary 
Heart Disease (CHD), because the ECG picture showed a T wave inversion.1 According 
to Sokolow-Lyon voltage criteria,LVH is a total S wave at V2 and R wave in wave V5> 
35 mm, and this result supports the patient's diagnosis of congestive heart failure.10 
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PA Thorax X-ray showed cardiomegaly and acute lung edema signs, 
accompanied by bilateral pleural effusion. This supports congestive heart failure as the 
cardiovascular complications in this hyperthyroid patient. Hepatomegaly and congestive 
signs of the liver was found from abdomen ultrasound examination. Hepatomegaly due 
to hepatic congestion are a sign of high output heart failure in hyperthyroid heart 
disease. This supports the picture of congestive heart failure as a cardiovascular 
complication in this hyperthyroid patient.5 
To determine the diagnosis of this patient, the diagnostic criteria for 
hyperthyroidism and hyperthyroid heart disease must be met. Hyperthyroidism in these 
patients is based on history, physical examination, and laboratory and radiology 
investigation. The gold standard is the examination of thyroid hormones levels, namely 
TSH levels, free T4, and T3. Unfortunately, in this patient it could not be done. Data 
that helps establish a diagnosis of hyperthyroidism in these patients are palpitations, 
history of diagnosis of hyperthyroidism in the past year and routine consumption of 
PTU, irregular pulse and heartbeat, exophthalmus oculi and atrial fibrillation.  
Atrial fibrillation was established based on complaints of palpitations 
accompanied by ECG images, which shown P waves of fibrillation and irregular 
distance of R-R. Coronary Heart Disease was established based on ECG results that 
showed a unifocal PVC image and in the T wave host house in lead V4-V6. The 
diagnosis of congestive heart failure was made based on the Framingham criteria6, 
which found 5 major criteria (neck venous distension, elevation of jugular venous 
pressure, cardiomegaly, acute pulmonary edema and S3 gallop) and 3 minor criteria 
(extremity edema, hepatomegaly, and pleural effusion). This fulfills the diagnostic 
criteria where at least 1 major criterion is found with 2 minor criteria.6  
During treatment at the hospital, this patient get medical and non-medical 
therapy. Non-medical therapy include total rest, heart diet that aim to reduce the burden 
of the heart with a soft, low salt, low calories, and high protein diet, and reduce all 
forms of stress both physically and psychologically which can aggravate the work of the 
heart. 
Medical therapy includes oxygen, supportive IV fluid, antithyroid drugs, beta 
blockers, diuretics, digitalis, anti-coagulants, and anti-angina. Two liter per minute nasal 
canal O2 was given as a supplementation therapy to help increase oxygen supply into the 
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lungs and thus reduce complaints of dyspnea in this patient. Supportive fluids, namely 
Ringer Lactate 18 drops per minute, was given to maintain hemodynamic and fluid 
balance in this patient. Given the condition of fluid overload  in this patient, the amount 
of fluid through the infusion is limited to about 1200-1300 cc/24 hours. 
100 mg of PTU tablets every 8 hours was the chosen antithyroid drug in  
hyperthyroidism. PTU has the work of inhibiting T4 changes to peripheral T3, so that 
PTU shows symptomatic treatment faster, most patients can be controlled for 
hyperthyroidism with 100-150 mg of PTU every 6-8 hours.612 However, from other 
literature, the appropriate dose for patient with Hyperthyroid disease is PTU 250 mg or 
400-600 mg/day. The dosage three times a day from PTU is reduced to 200 mg after 
about 2 weeks (tapering off), then gradually reduced to 100 mg after about 8 weeks. 
Subsequently the maintenance dose can be given 50 mg three times a day or 
approximately 1-1.5 year.11 In the administration of PTU, since the patient shows a 
different response, the dose must be monitored with plasma T4 and T3 levels. The time 
needed for plasma T4 and T3 to return to normal varies around 6-10 weeks.6 However, 
in these patients T4 and T3 serum levels were not monitored due to constraints to our 
hospital availability. They are guide us when to start and adjusting the antithyroid drug 
dosage during treatment, particulary if the patient have ventricular rate that is difficult to 
control with standard treatment.9  
20 mg of propranolol tablets per 8 hours is the drug of choice in 
hyperthyroidism, with recommended doses of 40-160 mg tablets/day in divided doses. 
This drug is a beta blocker class which is intended to reduce the work of the heart and 
fight the work of negative inotropic and chronotropic thyroid hormones. Propranolol 
will rest the heart and give longer diastolic filling time so that it will overcome the heart 
failure. Propranolol is also important to overcome the peripheral effects of thyroid 
hormones which stimulates beta-adrenergic receptors. Beta blockers are also 
suppressing the nervous system, which can reduce palpitations, anxiety, and 
hyperkinesis. Provision of propranolol can be stopped if therapy with PTU has shown 
good results. 13 In this patient the administration of propranolol was stopped at 5th-day 
care, because there was a clinical improvement response in patient after being given 
PTU medication. Bisoprolol 2.5 mg tablets per day is a beta blocker class of drugs given 
to patients when there are abnormalities of heart failure. The initial dose is 1/10 of the 
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target dose, gradually 2x titrated according to the patient's clinical response. The 
mechanism of action is similar to propanolol, only this drug works for a longer 
duration.11 
Furosemide IV injection 20 mg per 12 hours is a strong diuretic as the treatment 
of choice for patients who have heart failure. Administration of this drug is intended to 
reduce congestive signs and symptoms. Especially in this patient where fluid overload 
and high-output heart failure occurs. The initial dose given was 2x20 mg intravenously 
(40 mg daily dose) in 2 days of treatment, and it was greatly reducing the patient's 
congestive complaints. After that, Furosemide tab 10 mg was continued in the morning 
for maintenance.12 
Spironolactone 50 mg tablets per 8 hours is an aldosterone antagonist that works 
by carrying out competitive inhibition of aldosterone downstream of the distal tubule 
and the ducts of the colon in the renal cortex. In chronic heart failure, administration of 
spironolactone is intended to prevent myocardial remodeling. This drug is given with 
Furosemide to increase the diuresis effect and prevent hypokalemia. Adult doses range 
from 25-200 mg, but effective doses a day are on average 100 mg in single or divided 
doses. After 1 week of treatment, the dose of the drug spironolactone in this patient is 
reduced to the lowest daily dose, which is 25 mg once a day, every morning.9 
Spironolactone 50 mg tablets per 8 hours is an aldosterone antagonist that works by 
carrying out competitive inhibition of aldosterone downstream of the distal tubule and 
the ducts of the colon in the renal cortex. In chronic heart failure, administration of 
spironolactone is intended to prevent myocardial remodelling. This drug was given with 
Furosemide to increase the diuresis effect and prevent hypokalemia. Adult doses range 
from 25-200 mg, but effective doses on average are 100 mg a day in single or divided 
doses.12 After 1 week of treatment, the dose of spironolactone in this patient was 
reduced to the lowest daily dose, which was 25 mg once a day, every morning. 
Digoxin 0.125 mg tablets per 12 hours is still controversial, because of its 
negative chronotropic nature but positive inotropic. It is expected that the negative 
chronotropic will work to overcome the existing tachycardia, but the positive inotropic 
work can increase the work of the heart.12 However, in this patient heart failure is 
accompanied by atrial fibrillation which has received maximum therapy with beta-
blockers for 1 week of treatment. This was an indication of the use of digitalis in this 
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patient. The dose of digoxin is usually 0.125-0.25 mg a day in normal kidney function 
(in the elderly 0.0625 mg-0.125 mg, sometimes 0.25 mg).6 
Thromboaspilet 80 mg tablets per day is an anticoagulant recommended for 
cases of atrial fibrillation in young patients, without organic cardiac abnormalities, 
hypertension, or other independent risk factors that can cause embolism. Treatment with 
anticoagulants, especially if the condition returning to the sinus rhythm and euthyroid in 
3 days or more, is continued for 4 weeks later. Aspirin as antithrombotic has an 
effective dose of 80-320 mg per day.11 
ISDN 5 mg tablets per 12 hours is a group of nitrates commonly used in patients 
with complaints of angina. In these patients, a picture of unifocal PVC and lead V2-V4 
T wave inversion was found which showed the presence of coronary heart disease. In 
addition, patients also have abnormalities in congestive heart failure. Therefore, in these 
patients long-term oral ISDN therapy is given at a daily dose of 10 mg in divided 
doses.6 
ISDN 5 mg tablets per 12 hours is a group of nitrates commonly used in patients 
with complaints of angina. In this patient, a picture of unifocal PVC and lead V2-V4 T 
wave inversion was found which showed the presence of coronary heart disease. In 
addition, patients also have congestive heart failure. Therefore, in this patient, long-term 
oral ISDN therapy was given at a daily dose of 10 mg in divided doses.13 
One ampule of Ranitidine injection per 12 hours intravenously and 1 tablespoon 
of Antacids Syrup every 8 hours is the initial therapy for patients with suspected 
dyspepsia syndrome. In addition, this class of drugs also functions as an adjuvant drug 
in patients taking thromboaspilet drugs. The use of this drug was stopped after 1 week 
of patients' dyspepsia complaints improved.1 
 Ubidecarenone and bisacodyl tablets were given as adjunctive drugs on the 6th-
day care while coronary artery disease appeared on ECG finding. Ubideceranone 
functions as an antioxidant. In recent study, the use of antioxidant have a potential 
benefit in prevention of the coronary artery disease.14 Bisacodyl is a laxative agent that 
is intended to help reduce heart burden in patients, because it can reduce constipation-
induced pressor effects as triggers for cardiovascular events.15 
This patient was treated for 8 days in ICU, followed by 2 days in ward with 
good outcome. Early detection and intervention followed by close  monitoring is a key 
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management for patient with hyperthyroid heart disease, especially in male patient, to 
achieve better outcome although in hospital with lack of resources. Limitations in this 
case report are that the thyroid function (TSH and fT3/fT4) and echocardiography were 
not assessed because the lack of resources in marginal region.      
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Figure/Table 
Table 1. Serial ECG during the patient follow up 
Day of Care 
& 
Date 
ECG Finding 
Day-2 
18/3/2016 
• Atrial Fibrillation Normo Ventricular Response (NVR) HR 100x/minutes 
• Left Ventricular Hypertrophy (LVH) 
• Normoaxis 
Day-6 
22/3/2016 
• Atrial Fibrillation Normo Ventricular Response (NVR) HR 90x/minutes 
• Left Ventricular Hypertrophy( LVH) 
• Normoaxis 
• T-Inverted V4-V6 suggestive Iskemik Anterolateral 
Day-8 
24/3/2016 
• Atrial Fibrillation Normo Ventricular Response (NVR) HR 100x/minutes 
• Left Ventricular Hypertrophy( LVH) 
• Normoaxis 
• T-Inverted V4-V6 suggestive Iskemik Anterolateral 
•  PVC/VES Unifocal 
Day-9 
25/3/2016 
• Atrial Fibrillation Normo Ventricular Response (NVR) HR 80x/minutes 
• Left Ventricular Hypertrophy( LVH) 
• Normoaxis 
• T-Inverted V4-V6 suggestive Iskemik Anterolateral 
 
Table 2. Resume of the follow-up during treatment in the ICU 
Day of 
Care 
& 
Date 
Assessment Planning  Action* 
Day-0 
 
18/03 
2016 
• Palpitation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
 
• Check the liver function, renal 
function, lipid profile, and 
electrolyte serum. 
• Observation for the vital sign q 
4 hours 
• Perform serial ECG 
- O2 Nasal Canula 2 lpm 
- IVFD RL 20 dpm 
- Injection Ranitidin 1 amp/12 
hours/ IV 
- Propanolol 20 mg/8 hours/PO 
- Bisoprolol 2,5 mg/24 
hours/PO 
- PTU 100 mg/8 hours/PO 
 
Day-
1 
19/03 
2016 
  
• Atrial Fibrillation 
• Congestive Heart Failure 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Electrolyte  imbalance 
• Check for the routine 
hematology 
- IVFD RL 18 dpm 
- Antacida syrup 10 ml/8 
hours/PO 
Day-
2 
20/03 
2016 
• Atrial Fibrillation 
• Congestive Heart Failure 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Electrolyte  imbalance  
• Dyspepsia Syndrome 
• Check for the routine 
hematology 
- Antacida syrup 15 ml/8 
hours/PO 
Day- • CHF e.c. Hyperthyroid • Check for the albumin and - Spironolactone 50 mg/8 
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3 
21/03 
2016 
Heart Disease 
• Atrial Fibrillation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Electrolyte imbalance 
• Dyspepsia Syndrome 
• Ascites e.c. CHF dd/ 
hypoproteinemia and 
hypoalbuminemia 
protein total serum 
• Check for routine urinalysis 
• Perform chest X-Ray 
• Perform abdominal USG 
hours/PO 
Day-
4 
22/03 
2016 
• CHF e.c. Hyperthyroid 
Heart Disease 
• Atrial Fibrillation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Electrolyte imbalance 
• Dyspepsia Syndrome 
• Ascites e.c. CHF dd/ 
hypoproteinemia and 
hypoalbuminemia 
• Check for the electrolyte 
serum 
- Injection Furosemide 20 
mg/12 hours/IV 
Day-
5 
23/03 
2016 
• CHF e.c. Hyperthyroid 
Heart Disease 
• Atrial Fibrillation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Electrolit imbalance 
• Dyspepsia Syndrome 
• Hypoproteinemia and 
hypoalbuminemia 
 - Propanolol stop 
- High protein diet 
Day-
6 
24/03 
2016 
• CHF e.c. Hyperthyroid 
Heart Disease 
• Atrial Fibrillation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Dyspepsia Syndrome 
• Hypoproteinemia and 
hypoalbuminemia 
• Electrolyte Imbalance 
• Coronary Heart Disease 
• Check albumin serum - Aff Oxygen Nasal Canule 
- Stop Injection Ranitidin and 
Furosemide 
- Furosemide 10 mg tab/24 
hours/PO 
- Spironolactone 25 mg tab/24 
hours/PO 
- Isosorbid Dinytrate 5 mg tab/ 
12 hours/PO 
- Ubidecarenone 1 tablet/24 
hours/PO 
- Bisacodyl 2 tablet every night 
- Digoxin 0,125 mg tab/ 12 
hours/ PO 
- Thromboaspilet 1 tab/24 
hours/PO 
Day-
7 
25/03 
2016 
• CHF e.c. Hyperthyroid 
Heart Disease 
• Atrial Fibrillation 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Dyspepsia Syndrome 
• Hypoproteinemia and 
hypoalbuminemia 
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• Electrolyte Imbalance 
• Coronary Heart Disease 
Day-
8 
26/03 
2016 
• CHF e.c. Hyperthyroid 
Heart Disease 
• Arytmia 
• Hyperthyroid on treatment 
(PTU) 
• Trombocytopenia 
• Dyspepsia Syndrome 
• Hypoproteinemia and 
hypoalbuminemia 
• Electrolyte Imbalance 
• Coronary Heart Disease 
  - Digoxin 0,125 mg tab/24 
hours/PO 
- Move into ward 
* Writing for the same action is not repeated.  
 
 
 
 
 
 
 
 
Figure 1. Radiologic Examination On 6th-Day Care 
